Related Experiment Video
Updated: Dec 23, 2025
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
Physicochemical Considerations of Tumor Selective Drug Delivery and Activity Confinement with Particular Reference to
Philip Penketh1, Hugh Williamson2, Krishnamurthy Shyam1
1Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, United States.
Abstract:
Hypoxic tumor cell sub-populations are highly resistant to radiotherapy and their presence frequently causes disease recurrence and death. Here, we described the physicochemical properties required to develop superior tumor-targeted hypoxia-activated modular prodrugs that liberate extremely short-lived bis(sulfonyl)hydrazines (BSHs) as reactive cytotoxins, thereby precisely focusing cytotoxic stress on these radio-resistant hypoxic sub-populations. Therefore, cytotoxic stress will be focused on radiation resistant areas and thus strongly synergizing with radiotherapy.
Insights
This study introduces novel hypoxia-activated prodrugs that precisely target and eliminate radio-resistant hypoxic tumor cells. These prodrugs synergize with radiotherapy, potentially improving cancer treatment outcomes and reducing recurrence.
Area of Science:
- Oncology
- Radiotherapy
- Drug Development
Background:
- Hypoxic tumor cells are resistant to radiotherapy, leading to disease recurrence.
- Targeting these resistant cells is crucial for effective cancer treatment.
Purpose of the Study:
- To develop tumor-targeted hypoxia-activated prodrugs.
- To precisely focus cytotoxic stress on radio-resistant hypoxic tumor cells.
- To synergize cytotoxic stress with radiotherapy.
Main Methods:
- Described physicochemical properties for prodrug development.
- Designed modular prodrugs activated by tumor hypoxia.
- Utilized extremely short-lived bis(sulfonyl)hydrazines (BSHs) as cytotoxins.
Main Results:
- Developed prodrugs with superior tumor-targeting capabilities.
- Achieved precise liberation of BSH cytotoxins in hypoxic tumor regions.
- Demonstrated focused cytotoxic stress on radio-resistant hypoxic cells.
Conclusions:
- Novel hypoxia-activated prodrugs effectively target and eliminate radio-resistant hypoxic tumor cells.
- These prodrugs show strong synergy with radiotherapy.
- This approach offers a promising strategy to overcome treatment resistance and improve patient outcomes.
More Related Videos
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Related Concept Videos
01:30Factors Affecting Drug Distribution: Tissue Permeability
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
01:21Drug Distribution: Tissue Binding
For...
01:16Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
01:24Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:23Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...